Although the pro-inflammatory function of VCAM-1 in the pathogenesis of atherosclerosis and acute coronary syndromes is well-documented, efforts to translate this knowledge into targeted therapies have only recently developed. Here, VCAM1 is linked to acute coronary syndrome.